These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 20223820)

  • 1. Mutant p53-induced up-regulation of mitogen-activated protein kinase kinase 3 contributes to gain of function.
    Gurtner A; Starace G; Norelli G; Piaggio G; Sacchi A; Bossi G
    J Biol Chem; 2010 May; 285(19):14160-9. PubMed ID: 20223820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of inhibitor of differentiation 2, a target of mutant p53, is required for gain-of-function mutations.
    Yan W; Liu G; Scoumanne A; Chen X
    Cancer Res; 2008 Aug; 68(16):6789-96. PubMed ID: 18701504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gain-of-function mutant p53 upregulates CXC chemokines and enhances cell migration.
    Yeudall WA; Vaughan CA; Miyazaki H; Ramamoorthy M; Choi MY; Chapman CG; Wang H; Black E; Bulysheva AA; Deb SP; Windle B; Deb S
    Carcinogenesis; 2012 Feb; 33(2):442-51. PubMed ID: 22114072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of GRO1 as a critical determinant for mutant p53 gain of function.
    Yan W; Chen X
    J Biol Chem; 2009 May; 284(18):12178-87. PubMed ID: 19258312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-21 promotes hepatocellular carcinoma HepG2 cell proliferation through repression of mitogen-activated protein kinase-kinase 3.
    Xu G; Zhang Y; Wei J; Jia W; Ge Z; Zhang Z; Liu X
    BMC Cancer; 2013 Oct; 13():469. PubMed ID: 24112539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulforaphene inhibits esophageal cancer progression via suppressing SCD and CDH3 expression, and activating the GADD45B-MAP2K3-p38-p53 feedback loop.
    Han S; Wang Y; Ma J; Wang Z; Wang HD; Yuan Q
    Cell Death Dis; 2020 Sep; 11(8):713. PubMed ID: 32873775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of functional domains necessary for mutant p53 gain of function.
    Yan W; Chen X
    J Biol Chem; 2010 May; 285(19):14229-38. PubMed ID: 20212049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allele-specific silencing of mutant p53 attenuates dominant-negative and gain-of-function activities.
    Iyer SV; Parrales A; Begani P; Narkar A; Adhikari AS; Martinez LA; Iwakuma T
    Oncotarget; 2016 Feb; 7(5):5401-15. PubMed ID: 26700961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-derived p53 mutants induce NF-kappaB2 gene expression.
    Scian MJ; Stagliano KE; Anderson MA; Hassan S; Bowman M; Miles MF; Deb SP; Deb S
    Mol Cell Biol; 2005 Nov; 25(22):10097-110. PubMed ID: 16260623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.
    Gulati AP; Yang YM; Harter D; Mukhopadhyay A; Aggarwal BB; Benzil DL; Whysner J; Albino AP; Murali R; Jhanwar-Uniyal M
    Mol Carcinog; 2006 Jan; 45(1):26-37. PubMed ID: 16267831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting MKK3 as a novel anticancer strategy: molecular mechanisms and therapeutical implications.
    Baldari S; Ubertini V; Garufi A; D'Orazi G; Bossi G
    Cell Death Dis; 2015 Jan; 6(1):e1621. PubMed ID: 25633290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of gene expression by tumor-derived p53 mutants.
    Scian MJ; Stagliano KE; Ellis MA; Hassan S; Bowman M; Miles MF; Deb SP; Deb S
    Cancer Res; 2004 Oct; 64(20):7447-54. PubMed ID: 15492269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockage of NF-kappaB induces serine 15 phosphorylation of mutant p53 by JNK kinase in prostate cancer cells.
    Zerbini LF; Wang Y; Correa RG; Cho JY; Libermann TA
    Cell Cycle; 2005 Sep; 4(9):1247-53. PubMed ID: 16082226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TAp63gamma can substitute for p53 in inducing expression of the maspin tumor suppressor.
    Spiesbach K; Tannapfel A; Mössner J; Engeland K
    Int J Cancer; 2005 Apr; 114(4):555-62. PubMed ID: 15578720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 regulates FAK expression in human tumor cells.
    Golubovskaya VM; Finch R; Kweh F; Massoll NA; Campbell-Thompson M; Wallace MR; Cance WG
    Mol Carcinog; 2008 May; 47(5):373-82. PubMed ID: 17999388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of the mitochondrial transport protein, Tim50, by mutant p53 contributes to cell growth and chemoresistance.
    Sankala H; Vaughan C; Wang J; Deb S; Graves PR
    Arch Biochem Biophys; 2011 Aug; 512(1):52-60. PubMed ID: 21621504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncoprotein E7 from beta human papillomavirus 38 induces formation of an inhibitory complex for a subset of p53-regulated promoters.
    Saidj D; Cros MP; Hernandez-Vargas H; Guarino F; Sylla BS; Tommasino M; Accardi R
    J Virol; 2013 Nov; 87(22):12139-50. PubMed ID: 24006445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase C-dependent regulation of NAG-1/placental bone morphogenic protein/MIC-1 expression in LNCaP prostate carcinoma cells.
    Shim M; Eling TE
    J Biol Chem; 2005 May; 280(19):18636-42. PubMed ID: 15757899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear factor-kappaB-dependent expression of metastasis suppressor KAI1/CD82 gene in lung cancer cell lines expressing mutant p53.
    Shinohara T; Miki T; Nishimura N; Nokihara H; Hamada H; Mukaida N; Sone S
    Cancer Res; 2001 Jan; 61(2):673-8. PubMed ID: 11212267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated expression of p53 gain-of-function mutation R175H in endometrial cancer cells can increase the invasive phenotypes by activation of the EGFR/PI3K/AKT pathway.
    Dong P; Xu Z; Jia N; Li D; Feng Y
    Mol Cancer; 2009 Nov; 8():103. PubMed ID: 19917135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.